UNLV scientists successfully introduced nanoparticles with messenger RNA into the pancreas for the first time with 99% ...

COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are ...

New research shows Moderna and Pfizer’s mRNA vaccines may prime the immune system to attack cancer—even better than some ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

Historically, RSV has been associated with infants, but they are not the only group that can be affected by serious RSV ...

RNA-based COVID vaccines may enhance the immune response to certain cancer treatments. Advanced lung and skin cancer patients ...

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing mRNA. Achieving the opposite and stabilizing health-promoting mRNA is still ...

Arcturus Therapeutics (NASDAQ:ARCT) traded lower on Friday after Citi downgraded the San Diego, California-based biotech, citing mid-stage data the company posted this week for ARCT-032, a messenger ...

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...